glp 1 and bulimia GLP-1 Agonist for Binge Eating Disorder: Evidence Safety Tips for prescribing GLP-1s in

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, including a reduced risk of blindness

Break Down Heavy Meals and Prevent Digestive Discomfort

Among the unreported adverse events potentially linked to Ozempic are two deaths and one case of completed suicide, according to an FDA inspection report.

64% at 1 year and 84% at 2 years in those without diabetes Risk factors of discontinuation include lower income, older age, lower weight loss, cost, among others

ET GAITHERSBURG, Md., May 13, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc